Insider Transactions in Q1 2024 at Citius Pharmaceuticals, Inc. (CTXR)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2024
|
Eugene Myron Holuka Director |
SELL
Payment of exercise price or tax liability
|
Direct |
48
-1.99%
|
$0
$0.75 P/Share
|
|
Mar 13
2024
|
Eugene Myron Holuka Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,415
+50.0%
|
$0
$0.02 P/Share
|
|
Mar 04
2024
|
Carol Webb Director |
SELL
Payment of exercise price or tax liability
|
Direct |
236
-1.96%
|
$0
$0.77 P/Share
|
|
Mar 04
2024
|
Carol Webb Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,071
+50.0%
|
$0
$0.02 P/Share
|